药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glycopyrronium
Eltrombopag
The metabolism of Fusidic acid can be decreased when combined with Eltrombopag.
Glycopyrronium
Deferasirox
The metabolism of Fusidic acid can be decreased when combined with Deferasirox.
Glycopyrronium
Flunitrazepam
The metabolism of Fusidic acid can be decreased when combined with Flunitrazepam.
Glycopyrronium
Gemfibrozil
The metabolism of Fusidic acid can be decreased when combined with Gemfibrozil.
Glycopyrronium
Fenofibric acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Fenofibric acid.
Glycopyrronium
Clofibride
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Clofibride.
Glycopyrronium
Aluminium clofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Aluminium clofibrate.
Glycopyrronium
Ronifibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Ronifibrate.
Glycopyrronium
Simfibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Simfibrate.
Glycopyrronium
Emetine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Emetine.
Glycopyrronium
Mebeverine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Mebeverine.
Glycopyrronium
Ubidecarenone
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Ubidecarenone.
Glycopyrronium
Ciprofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Ciprofibrate.
Glycopyrronium
Acipimox
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Acipimox.
Glycopyrronium
Etofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Etofibrate.
Glycopyrronium
Raltegravir
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Raltegravir.
Glycopyrronium
Procarbazine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Fusidic acid.
Glycopyrronium
Clorindione
The risk or severity of bleeding can be increased when Fusidic acid is combined with Clorindione.
Glycopyrronium
Fluindione
The risk or severity of bleeding can be increased when Fusidic acid is combined with Fluindione.
Glycopyrronium
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Fusidic acid is combined with 4-hydroxycoumarin.